Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) currently has a daily average trading volume of 2.10M but it saw 3042423 shares traded in last market. With a market cap of 10.59B USD, the company’s current market price of $12.71 came falling about -2.38 while comparing to the previous closing price of $13.02. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.89 and as low as $12.26. In the recent trading on the day, stock has struck highest price mark of $12.38 while lowest mark touched by it was $12.96.
Taking a look at 20-day trading activity of Dr. Reddy’s Laboratories Ltd. ADR (RDY) gives us an average price of $13.14, while its current price level is -24.76% below from 52-week high level whereas it is 3.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $13.26 while that of 200 days or SMA-200 reads an average of $14.91. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.82% during that period while stretching the period over a month that decreases to 1.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.88 which implies that the stock is in neutral territory.
Over the week, RDY’s stock price is moving -4.00% down while it is 1.44% when we observe its performance for the past one month. Year-to-date it is -19.51% down and over the past year, the stock is showing a downside performance of -13.99%.
The company is expected to be releasing its next quarterly report on 2025-Jan-22, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 70.93. In next quarter, company is expected to be making quarterly sales of $88.32B as analysts are expecting the sales for current fiscal year at $323.36B and seeing the company making $352.52B in sales next year. Moreover, analysts are in estimates of $83.75B for current-quarter revenue.
Currently, Dr. Reddy’s Laboratories Ltd. ADR’s total number of outstanding shares is 834.42M with 0.00% of that held by the insiders while 15.02% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 16.88% and return on equity (ROE) at 18.51%. It has a price to earnings ratio (P/E ratio) of 16.53 while having a 15.84 of forward P/E ratio. Stock’s beta reads 0.34. Stock has a price to book (P/B) ratio of 2.86 while price to sale or P/S ratio amounts to 2.85. Its return on asset (ROA) is 12.70% on average.
